148 related articles for article (PubMed ID: 12593442)
1. Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma.
Kumar S; Wairagkar NS; Mahanta J
Indian J Cancer; 2001; 38(2-4):72-5. PubMed ID: 12593442
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
[TBL] [Abstract][Full Text] [Related]
3. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of detection of Epstein-Barr virus Rta/IgG in nasopharyngeal carcinoma].
Zheng YM; Cain YL; Cheng JR; Li J; Mo YK; Gao JQ; Dong ZR; Zhong QY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):285-7. PubMed ID: 20108775
[TBL] [Abstract][Full Text] [Related]
5. [The purification and application of Epstein-Barr virus gp125].
Wang G; Pi G; Gu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):143-6. PubMed ID: 12515193
[TBL] [Abstract][Full Text] [Related]
6. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus in nasopharyngeal carcinoma in Indian patients.
Rathaur RG; Chitale AR; Banerjee K
Indian J Cancer; 1999; 36(2-4):80-90. PubMed ID: 10921211
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.
Friborg J; Jarrett RF; Liu MY; Falk KI; Koch A; Olsen OR; Duncan P; Wohlfarht J; Chen JY; Melbye M
J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the efficiency of Epstein-Barr viral serologic test in the diagnosis of nasopharyngeal carcinoma.
Zhang C; Zong Y; Huang B; Sun Y; Ye Y; Feng K; Li J; Zhang F
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):356-9. PubMed ID: 12408763
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
12. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P
J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
14. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus.
Nadala EC; Tan TM; Wong HM; Ting RC
J Med Virol; 1996 Sep; 50(1):93-6. PubMed ID: 8890046
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma.
Liu MY; Chang YL; Ma J; Yang HL; Hsu MM; Chen CJ; Chen JY; Yang CS
J Med Virol; 1997 Jul; 52(3):262-9. PubMed ID: 9210034
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and viral studies in nasopharyngeal carcinomas in patients of Indian origin.
Kumari P; Augustus M; Naik U; Ravi V; Shenoy AM; Rao CR; Kumar RV
Indian J Cancer; 1995 Mar; 32(1):10-4. PubMed ID: 7558105
[TBL] [Abstract][Full Text] [Related]
17. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH
J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
[TBL] [Abstract][Full Text] [Related]
18. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
[TBL] [Abstract][Full Text] [Related]
19. [Development of new methods for the diagnosis of nasopharyngeal carcinoma].
Pi GH; Cheng DS; Zhou Y; Zhang WL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):65-7. PubMed ID: 20848856
[TBL] [Abstract][Full Text] [Related]
20. Detection of Epstein-Barr virus DNA in plasma/serum: a useful serological indicator for diagnosis of nasopharyngeal carcinoma.
Mai S; Zong Y; Zhang M; Zhong B; Lin S
Chin Med J (Engl); 2002 Dec; 115(12):1895-7. PubMed ID: 12622949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
